Menthol (CAS NO : 1490-04-06)

The global menthol market, currently valued at approximately USD 965 million and projected to exceed USD 1.2 billion by 2032, is undergoing a significant structural shift driven by the rapid industrialisation of synthetic menthol production which now challenges the traditional dominance of natural L-menthol derived from Mentha arvensis. While natural menthol still commands a major market share of over 70%, the sector is increasingly influenced by the strategic capacity expansions of key chemical conglomerates like BASF, which utilises advanced citral-based catalytic hydrogenation to ensure high-purity supply independent of the climatic volatility and supply chain vulnerabilities associated with Indian and Chinese mint harvests. Pharmaceutical applications remain a primary growth catalyst, particularly for 99% purity grades used in topical analgesics, oral care, and decongestants, although the industry faces regulatory headwinds in the tobacco sector as the U.S. and EU implement bans on menthol-flavoured cigarettes to curb nicotine addiction. As a globally established Menthol supplier with >= 99% purity, we ensure dependable supply, consistent quality, and complete regulatory documentation, including Menthol CoA and Menthol TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.